Improved drug–target interaction prediction with intermolecular graph transformer. Issue 5 (5th May 2022)

• Record Type: Journal Article
• Authors: Liu, Siyuan; Wang, Yusong; Deng, Yifan; He, Liang; Shao, Bin; Yin, Jian; Zheng, Nanning; Liu, Tie-Yan; Wang, Tong
• Is Part Of: Briefings in bioinformatics. Volume 23:Issue 5(2022)
• Publication Date: 2022-05-05
• Subjects: drug–target Interaction -- Intermolecular Graph Transformer -- deep learning -- drug discovery; Genetics -- Data processing -- Periodicals; Molecular biology -- Data processing -- Periodicals; Genomes -- Data processing -- Periodicals; 572.80285
• DOI: 10.1093/bib/bbac162
• Languages: English
• ISSNs: 1467-5463

Abstract

Abstract: The identification of active binding drugs for target proteins (referred to as drug–target interaction prediction) is the key challenge in virtual screening, which plays an essential role in drug discovery. Although recent deep learning-based approaches achieve better performance than molecular docking, existing models often neglect topological or spatial of intermolecular information, hindering prediction performance. We recognize this problem and propose a novel approach called the Intermolecular Graph Transformer (IGT) that employs a dedicated attention mechanism to model intermolecular information with a three-way Transformer-based architecture. IGT outperforms state-of-the-art (SoTA) approaches by 9.1% and 20.5% over the second best option for binding activity and binding pose prediction, respectively, and exhibits superior generalization ability to unseen receptor proteins than SoTA approaches. Furthermore, IGT exhibits promising drug screening ability against severe acute respiratory syndrome coronavirus 2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses. Source code and datasets are available at https://github.com/microsoft/IGT-Intermolecular-Graph-Transformer .